Clinical trial
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in…
NCT00359840 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00359840 |
|---|---|
| Title | A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor |
| Official title | A Randomized, Dose - Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | darbepoetin alfa |
| Enrollment | 120 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2007 |
| First posted | Aug 3, 2006 |
| Last update posted | Aug 31, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: